01 1Maprimed
01 1OZANIMOD HYDROCHLORIDE
01 1Argentina
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-10
Pay. Date : 2023-09-15
DMF Number : 38622
Submission : 2023-09-22
Status : Active
Type : II
20
Maprimed Sa, based in Argentina, is a pharmaceutical company.
One of their notable products is OZANIMOD HYDROCHLORIDE, with a corresponding US DMF Number 38622.
Remarkably, this DMF maintains an Active status since its submission on September 22, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 10, 2023, and payment made on September 15, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
